AK Medical Holdings Limited (HKG:1789)

CTI BioPharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,365	5,445	7,023	10,923	7,364	15,015
Market Cap Growth	-22.47%	-22.47%	-35.70%	48.34%	-50.96%	62.45%
Enterprise Value	6,439	4,655	6,173	9,917	6,411	14,035
Last Close Price	6.56	4.79	6.12	9.49	6.36	12.93
PE Ratio	25.69	18.68	35.01	47.19	64.77	40.26
Forward PE	19.44	15.77	20.98	37.23	32.47	28.97
PS Ratio	5.14	3.80	5.83	9.18	7.88	12.21
PB Ratio	2.62	1.94	2.67	4.31	2.95	6.19
P/TBV Ratio	2.83	2.10	2.91	4.72	3.30	6.90
P/FCF Ratio	23.20	17.16	-	75.65	50.90	105.35
P/OCF Ratio	15.34	11.34	187.86	39.78	33.97	61.60
PEG Ratio	0.59	0.77	0.77	0.77	0.77	0.77
EV/Sales Ratio	4.49	3.25	5.12	8.34	6.86	11.42
EV/EBITDA Ratio	15.30	11.58	19.84	29.21	33.30	28.05
EV/EBIT Ratio	20.12	14.54	26.49	36.80	52.53	31.28
EV/FCF Ratio	20.29	14.67	-	68.68	44.32	98.48
Debt / Equity Ratio	0.04	0.04	0.04	0.02	0.02	0.01
Debt / EBITDA Ratio	0.25	0.25	0.28	0.12	0.24	0.06
Debt / FCF Ratio	0.33	0.33	-	0.30	0.35	0.22
Asset Turnover	0.43	0.43	0.38	0.39	0.30	0.52
Inventory Turnover	0.99	0.99	0.84	1.01	0.67	1.09
Quick Ratio	2.69	2.69	2.65	3.66	2.84	3.52
Current Ratio	3.65	3.65	3.96	4.73	3.95	4.55
Return on Equity (ROE)	10.89%	10.89%	7.86%	9.58%	4.55%	19.88%
Return on Assets (ROA)	5.93%	5.93%	4.58%	5.54%	2.42%	11.78%
Return on Capital (ROIC)	7.21%	7.21%	5.56%	6.84%	3.00%	14.77%
Return on Capital Employed (ROCE)	11.00%	11.00%	8.40%	10.20%	4.70%	17.90%
Earnings Yield	3.96%	5.35%	2.86%	2.12%	1.54%	2.48%
FCF Yield	4.31%	5.83%	-2.35%	1.32%	1.97%	0.95%
Dividend Yield	1.10%	1.50%	0.73%	0.63%	0.39%	0.31%
Payout Ratio	16.83%	16.83%	33.78%	11.70%	39.62%	24.01%
Buyback Yield / Dilution	0.05%	0.05%	-0.15%	0.28%	-1.21%	-4.61%
Total Shareholder Return	1.14%	1.55%	0.58%	0.91%	-0.82%	-4.31%

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.